Loading, please wait ...


News Analytics

Blue Chip Pharmaceuticals Stocks Contend With Political Headwinds.
“We expect Congress will struggle to pass any system that includes significant Medicare price negotiation, such as pegging prices to international prices or deeply discounted (Medicaid, VA) U.S. prices, given pressure from more moderate Democrats in the Senate,” says Morningstar analyst Karen Andersen.

Subject Matter

  • Business, economics, society 100.00%
    • Labor issues 51.11%
    • Companies, industries, organizations 48.89%

Emotional Reaction

Sentiment

Positive

Neutral

Negative

Definitions